Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial (Q33441802)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial |
scientific article |
Statements
1 reference
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial (English)
1 reference
Piero Picci
1 reference
Emanuela Marchesi
1 reference
Javier Martin Broto
1 reference
Antonio Lopez Pousa
1 reference
Iwona Lugowska
1 reference
Stefano Ferrari
1 reference
Vittorio Quagliuolo
1 reference
Giovanni Grignani
1 reference
Oscar Tendero
1 reference
Robert Diaz Beveridge
1 reference
Valeria Fontana
1 reference
Elena Palassini
1 reference
Emanuela Palmerini
1 reference
Carlo Morosi
1 reference
Silvia Bagué
1 reference
Jean Michelle Coindre
1 reference
Paolo Bruzzi
1 reference
9 May 2017
1 reference
1 reference
18
1 reference
812-822
1 reference
Identifiers
1 reference
1 reference